Visualization of membrane localization and the functional state of CB 2 R pools using matched agonist and inverse agonist probe pairs.

Autor: Wąsińska-Kałwa M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Omran A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Mach L; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Scipioni L; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Bouma J; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Li X; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China., Radetzki S; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Mostinski Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Schippers M; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Gazzi T; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., van der Horst C; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Brennecke B; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Hanske A; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Kolomeets Y; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Guba W; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Sykes D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK., von Kries JP; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Broichhagen J; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de., Hua T; iHuman Institute, ShanghaiTech University Shanghai 201210 China.; School of Life Science and Technology, ShanghaiTech University Shanghai 201210 China., Veprintsev D; Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.; Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, University of Nottingham Midlands UK., Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University 2333 CC Leiden The Netherlands., Oddi S; Department of Veterinary Medicine, University of Teramo Via R. Balzarini 1 64100 Teramo Italy soddi@unite.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila 67100 L'Aquila Italy mauro.maccarrone@univaq.it.; European Center for Brain Research/Institute for Research and Health Care (IRCCS) Santa Lucia Foundation via del Fosso di Fiorano 64 00143 Rome Italy., Grether U; Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd 4070 Basel Switzerland uwe.grether@roche.com., Nazare M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie FMP Campus Berlin-Buch 13125 Berlin Germany nazare@fmp-berlin.de.

Publikováno v: Chemical science [Chem Sci] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.

Influence of Training and Single Exercise on Leptin Level and Metabolism in Obese Overweight and Normal-Weight Women of Different Age.

Autor: Murawska-Ciałowicz E; Physiology and Biochemistry Department, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland., Kaczmarek A; Physiology and Biochemistry Department, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland., Kałwa M; Sport Didactics Department, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland., Oniszczuk A; Physiology and Biochemistry Department, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Sep 26; Vol. 19 (19). Date of Electronic Publication: 2022 Sep 26.

Discovery and development of CPL207280 as new GPR40/FFA1 agonist.

Autor: Mach M; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland. Electronic address: mateusz.mach@celonpharma.com., Bazydło-Guzenda K; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland; Postgraduate School of Molecular Medicine, Medical University of Warsaw, 61 Zwirki i Wigury Street, 02-091, Warsaw, Poland., Buda P; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Matłoka M; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Dzida R; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Stelmach F; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Gałązka K; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Wąsińska-Kałwa M; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Smuga D; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Hołowińska D; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Dawid U; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Gurba-Bryśkiewicz L; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Wiśniewski K; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Dubiel K; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Pieczykolan J; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland., Wieczorek M; Celon Pharma S.A., R&D Centre, Marymoncka 15, 05-152, Kazun Nowy, Poland.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2021 Dec 15; Vol. 226, pp. 113810. Date of Electronic Publication: 2021 Sep 01.

Silver(I) complex with 2-amino-4,4α-dihydro-4α,7-dimethyl-3 H -phenoxazin-3-one (Phx-1) ligand: crystal structure, vibrational spectra and biological studies.

Autor: Helios, K., Maniak, H., Sowa, M., Zierkiewicz, W., Wąsińska-Kałwa, M., Giurg, M., Drożdżewski, P., Trusek-Hołownia, A., Malik, M., Krauze, K.

Publikováno v: Journal of Coordination Chemistry; Oct2017, Vol. 70 Issue 20, p3471-3487, 17p

SETTING HEALTH TRAINING OBJECTIVES BASED ON THE ASSESSMENT OF PREFERRED AREAS OF HEALTH BEHAVIOR IN A GROUP OF ACTIVE WOMEN WITH CHRONIC BACK PAIN: A PILOT STUDY OF THE CROSS-SECTIONAL RESEARCH.

Autor: KAŁWA, MAŁGORZATA¹ malgorzata.kalwa@awf.wroc.pl, MYRNA-BEKAS, RENATA², DĘBSKA, URSZULA³

Publikováno v: Medical Science Pulse. 2022, Vol. 16 Issue 4, p9-18. 10p.